Monte Rosa Therapeutics, Inc. short interest in 2023
In 2023, Monte Rosa Therapeutics, Inc.'s disclosed short interest ran from 7.77% of shares outstanding on 13 Jan 2023 to 4.11% on 29 Dec 2023, a change of -3.66 percentage points. The year's high was 8.11% on 29 Sep 2023 and its low 4.11% on 29 Dec 2023, averaging 5.81% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 34.98 days on 31 Jan 2023. Full history: Monte Rosa Therapeutics, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 7.77% (13 Jan 2023)
- End of year
- 4.11% (29 Dec 2023)
- Change
- -3.66 pp
- High
- 8.11% (29 Sep 2023)
- Low
- 4.11% (29 Dec 2023)
- Average
- 5.81%
- Highest days to cover
- 34.98 (31 Jan 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 7.77% | 20.32 | |
| 31 Jan 2023 | 7.71% | 34.98 | |
| 15 Feb 2023 | 5.15% | 11.21 | |
| 28 Feb 2023 | 4.73% | 24.43 | |
| 15 Mar 2023 | 4.49% | 20.98 | |
| 31 Mar 2023 | 4.90% | 21.67 | 10-K filed, results (8-K) |
| 14 Apr 2023 | 5.05% | 10.10 | |
| 28 Apr 2023 | 4.54% | 8.74 | |
| 15 May 2023 | 4.64% | 10.63 | 10-Q filed, results (8-K) |
| 31 May 2023 | 4.65% | 13.76 | |
| 15 Jun 2023 | 4.95% | 11.87 | |
| 30 Jun 2023 | 5.23% | 12.16 | |
| 14 Jul 2023 | 5.34% | 30.13 | |
| 31 Jul 2023 | 5.66% | 30.21 | |
| 15 Aug 2023 | 6.30% | 20.72 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 7.20% | 19.20 | |
| 15 Sep 2023 | 7.75% | 20.62 | |
| 29 Sep 2023 | 8.11% | 24.14 | |
| 13 Oct 2023 | 7.56% | 20.38 | |
| 31 Oct 2023 | 6.78% | 5.61 | |
| 15 Nov 2023 | 6.10% | 14.56 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 5.93% | 16.09 | |
| 15 Dec 2023 | 4.71% | 6.77 | |
| 29 Dec 2023 | 4.11% | 8.45 |
See also: Monte Rosa Therapeutics, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.